Karen Lewis - 23 Jan 2023 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Chief People Officer
Signature
/s/ David Watson, attorney-in-fact for Karen Lewis
Issuer symbol
APLS
Transactions as of
23 Jan 2023
Net transactions value
-$152,419
Form type
4
Filing time
25 Jan 2023, 15:17:44 UTC
Previous filing
24 Jan 2023
Next filing
30 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale $152,419 -2,955 -7.3% $51.58 37,709 23 Jan 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale originated from established 10b5-1 trading plan.